MedPath

CLEAR CREEK BIO, INC.

CLEAR CREEK BIO, INC. logo
🇺🇸United States
Ownership
Private
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://www.clearcreekbio.com

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

Phase 2
Terminated
Conditions
COVID-19
Interventions
First Posted Date
2021-12-22
Last Posted Date
2023-11-07
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
26
Registration Number
NCT05166876
Locations
🇮🇳

RIMS - Government Medical College, Srikakulam, Andhra Pradesh, India

🇮🇳

King George Hospital, Visakhapatnam, Andhra Pradesh, India

🇮🇳

JIPMER Hospital, Pondicherry, Puducherry, India

and more 4 locations

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Phase 2
Completed
Conditions
COVID-19 Infection
Interventions
Drug: Placebo
First Posted Date
2020-10-05
Last Posted Date
2022-04-19
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
115
Registration Number
NCT04575038
Locations
🇺🇸

Synexus Clinical Research US, Inc. - Olympus Family Medicine, Salt Lake City, Utah, United States

🇺🇸

Ark Clinical Research, Long Beach, California, United States

🇺🇸

Central Alabama Research, Homewood, Alabama, United States

and more 11 locations

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

Phase 1
Completed
Conditions
COVID-19
Interventions
Other: Standard of Care
First Posted Date
2020-06-11
Last Posted Date
2022-02-17
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
25
Registration Number
NCT04425252
Locations
🇺🇸

University of South Florida/Tampa General, Tampa, Florida, United States

🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

Temple University, Philadelphia, Pennsylvania, United States

and more 2 locations

A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1
Terminated
Conditions
Acute Myeloid Leukemia
Interventions
First Posted Date
2018-11-30
Last Posted Date
2022-08-08
Lead Sponsor
Clear Creek Bio, Inc.
Target Recruit Count
17
Registration Number
NCT03760666
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath